Clinical Trial Update: Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease [Phase 3]

View source ↗

Summary

TA-650's Phase 3 study in pediatric Crohn's disease has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• TA-650

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Pediatric Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-07-05